ISPOR UAE Chapter, AbbVie partner to improve patient outcomes and healthcare in the UAE

UAE—The ISPOR UAE Chapter, the nation’s branch of the leading international organisation for health economics and outcomes research (HEOR), has announced a collaborative initiative with AbbVie, a global biopharmaceutical company, to advance healthcare outcomes across the United Arab Emirates.

This partnership was formalised through a Letter of Intent (LOI) signed during Abu Dhabi Global Health Week, attended by senior representatives from both organisations.

The LOI marks a shared commitment to exploring joint opportunities to strengthen key areas such as Health Technology Assessment (HTA), policy development, and research-driven evidence generation.

The collaboration aims to build a more robust, data-driven healthcare system in the UAE by combining the ISPOR UAE Chapter’s extensive network and expertise in HEOR with AbbVie’s scientific and biopharmaceutical capabilities.

During the signing, Prof. Nadia Al Mazrouei, President of the ISPOR UAE Chapter, highlighted the organization’s dedication to excellence in health economics and outcomes research.

She emphasized that this partnership is a pivotal step in connecting researchers, policymakers, and healthcare professionals with industry leaders.

The goal is to foster impactful research and develop evidence-based policies that will ultimately benefit patients throughout the UAE.

Echoing this sentiment, Elhussein Abdellatif, Abbvie’s General Manager for Gulf Levant, reaffirmed AbbVie’s commitment to elevating standards of care and improving patient lives.

 He underscored the vital role of HTA and sound health policy in ensuring access to essential therapies.

According to Abdellatif, collaborating with the ISPOR UAE Chapter presents an opportunity for AbbVie to share its expertise and work collectively toward a more sustainable, patient-centred healthcare ecosystem in the country.

This partnership aligns with broader trends in the UAE’s healthcare sector, which is placing a growing emphasis on innovation, personalized medicine, and the integration of advanced technologies.

For example, Abu Dhabi has recently launched major initiatives such as the Health, Endurance, Longevity, and Medicine (HELM) cluster, which aims to position the emirate as a global hub for biotechnology, MedTech, and digital health.

These efforts are reinforced by strategic collaborations with international biopharmaceutical leaders like AbbVie, which are helping to drive research, clinical trials, and the adoption of innovative therapies tailored to the region’s unique healthcare needs.

Through this LOI, the ISPOR UAE Chapter and AbbVie are setting the stage for a series of collaborative projects that will leverage real-world evidence, support policy shaping, and enhance the effectiveness of patient support programs.

Both organizations are enthusiastic about the potential to deliver research that informs policy decisions and improves patient outcomes, further establishing the UAE as a leader in evidence-based healthcare innovation.

Sign up HERE to receive our email newsletters with the latest news and insights from Africa and beyond. Also, follow us on our WhatsApp channel for updates.